<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25841" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Physiology, Neurotransmitters</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sheffler</surname>
            <given-names>Zachary M.</given-names>
          </name>
          <aff>LECOM</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Reddy</surname>
            <given-names>Vamsi</given-names>
          </name>
          <aff>McKinsey &#x00026; Company</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pillarisetty</surname>
            <given-names>Leela Sharath</given-names>
          </name>
          <aff>Midland Memorial / Texas Tech University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Zachary Sheffler declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vamsi Reddy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Leela Sharath Pillarisetty declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25841.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Neurotransmitters are endogenous chemicals that allow neurons to communicate with each other&#x000a0;throughout the body. They enable the brain to provide a variety of functions, through the process of chemical synaptic transmission. These endogenous chemicals are integral in shaping everyday life and functions.<xref ref-type="bibr" rid="article-25841.r1">[1]</xref></p>
        <p>Chemical synaptic transmission primarily through the release of neurotransmitters from presynaptic neural cells&#x000a0;to postsynaptic receptors. Alterations in the levels of specific neurotransmitters have been observed in various neurological disorders, including Parkinson disease, schizophrenia, depression, and Alzheimer disease.</p>
      </sec>
      <sec id="article-25841.s2" sec-type="Development">
        <title>Development</title>
        <p>Neurotransmitters are involved in the processes of early human development, including neurotransmission, differentiation, the growth of neurons, and the development of neural circuitry. Certain neurotransmitters may appear at different points of development. For example, monoamines are present before the neurons are differentiated. Norepinephrine levels are high in the notochord, even in the very early stages of the embryo. Serotonin has a role in morphogenesis. Excitatory amino acids tend to appear later in ontogenesis. The levels of neurotransmitters and neuromodulators tend to increase as new synapses form. Others will appear&#x000a0;in the perinatal period, like glutamate, and plateau afterward. Hypoxia and drug-exposure can disturb the formation of neuronal circuity, leading to long-term deleterious effects in the body.<xref ref-type="bibr" rid="article-25841.r2">[2]</xref><xref ref-type="bibr" rid="article-25841.r3">[3]</xref></p>
      </sec>
      <sec id="article-25841.s3" sec-type="Function">
        <title>Function</title>
        <p>There are a number of neurotransmitters used by the body for different functions, including acetylcholine, glutamate, GABA, glycine, dopamine, norepinephrine, and serotonin. Glutamate is the principal excitatory neurotransmitter used in the brain. It is also the primary mediator of nervous system plasticity.<xref ref-type="bibr" rid="article-25841.r4">[4]</xref> Glutamate has been implicated in modifiable synapses, which researchers suspect are the memory-storage elements of the brain.<xref ref-type="bibr" rid="article-25841.r5">[5]</xref> Gamma-aminobutyric acid (GABA) and glycine, conversely, serve as the major inhibitory neurotransmitters. GABA, for example, can account for approximately 40% of the inhibitory processing in the brain. Glycine is found primarily in the spinal cord.<xref ref-type="bibr" rid="article-25841.r6">[6]</xref> Dopamine, another major neurotransmitter, plays an essential role in several brain functions, including learning, motor control, reward, emotion, and executive functions. Dopamine has also been implicated in psychiatric and neurological disorders.<xref ref-type="bibr" rid="article-25841.r7">[7]</xref> Serotonin is a neurotransmitter that modulates multiple neuropsychological processes and neural activity &#x02014; many drugs used in psychiatry and neurology target serotonin. Serotonin also has implications that affect gastrointestinal processes like bowel motility, bladder control, and cardiovascular function.<xref ref-type="bibr" rid="article-25841.r8">[8]</xref> Norepinephrine is a monoamine that is synthesized in the central nervous system and sympathetic nerves. The locus coeruleus of the brain plays a vital role in the signaling of norepinephrine. The release of norepinephrine in the brain exerts effects on a variety of processes, including stress, sleep, attention, focus, and inflammation. It also plays a role in modulating the responses of the autonomic nervous system.<xref ref-type="bibr" rid="article-25841.r9">[9]</xref> Histamine is another neurotransmitter that mediates homeostatic functions in the body, promotes wakefulness, modulates feeding behavior, and controls motivational behavior.<xref ref-type="bibr" rid="article-25841.r10">[10]</xref></p>
      </sec>
      <sec id="article-25841.s4" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>Neurotransmission medication occurs via the vesicular release of neurotransmitters at presynaptic nerve terminals. Specifically, calcium-evoked exocytosis of the presynaptic vesicles is what enables the release of neurotransmitters into the synapse. Active zones, specialized areas on the presynaptic plasma membranes, tether the neurotransmitter-containing vesicles to the plasma membrane. Once an action potential triggers calcium influx into the presynaptic cleft, active zones undergo fusion with the vesicles, allowing neurotransmitter release.<xref ref-type="bibr" rid="article-25841.r1">[1]</xref>&#x000a0;There are multiple proteins involved in the fusion of neurotransmitter-containing vesicles and the active zone. The soluble N-ethyl maleimide sensitive factor attachment protein receptors (SNAREs) syntaxin-1, SNAP-25, and synaptobrevin-2 together form a SNARE complex, a key component in membrane fusion and ultimately exocytosis. A number of the proteins involved in this process may act as inhibitors and activators of the exocytosis of neurotransmitters from the presynapse.<xref ref-type="bibr" rid="article-25841.r11">[11]</xref></p>
      </sec>
      <sec id="article-25841.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The neurotransmitter glutamate has been implicated in multiple neurodegenerative studies. Researchers agree that glutamate excitotoxicity undoubtedly has a role in the pathogenesis of Alzheimer disease, the most common neurodegenerative pathology affecting the elderly population. Research suggests glutamate excitotoxicity accelerates the progression of Alzheimer disease.<xref ref-type="bibr" rid="article-25841.r12">[12]</xref> Glutamate is also implicated in the pathogenesis of Parkinson disease. Mutations in genes encoding the parkin and DJ1 proteins are present in Parkinson disease, which are involved in the regulation of excitatory glutamate synapses. These proteins may also protect neurons against glutamate excitotoxicity.<xref ref-type="bibr" rid="article-25841.r13">[13]</xref><xref ref-type="bibr" rid="article-25841.r14">[14]</xref></p>
      </sec>
      <sec id="article-25841.s6" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Gamma-aminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous system, is targeted in the treatment of anxiety disorder, insomnia, epilepsy, and other conditions. In particular, these drugs alter GABAergic function by targeting the GABA-A and GABA-B receptors.<xref ref-type="bibr" rid="article-25841.r15">[15]</xref></p>
        <p>Not only does dopamine play an important role in multiple physiological processes, but it also has a role in the pathology of psychiatric and neurodegenerative diseases. Disturbances in the neurotransmission of dopamine are implicated in schizophrenia, psychosis, depression, Tourette syndrome, and attention deficit hyperactivity disorder. Regarding neurodegenerative diseases, dopamine is related to Parkinson disease, multiple sclerosis, and Huntington disease. There has been ample research on the role of dopaminergic neurons in Parkinson disease. Currently, research suggests that the degeneration of dopaminergic neurons in the substantia nigra pars compacta is involved in the pathogenesis of Parkinson disease.<xref ref-type="bibr" rid="article-25841.r16">[16]</xref></p>
        <p>Serotonin, a neurotransmitter that controls several neuropsychiatric processes, has been implicated in the pathogenesis of depression. Research has shown that patients with endogenous depression have low plasma levels of tryptophan, a precursor of serotonin. Furthermore, postmortem studies found an association between decreased serotonin levels in the brain and suicide, among depressed patients. In light of this, quite a few drugs have been developed that target serotonin in the treatment of depression. For example, tricyclic antidepressants work by increasing serotonin levels in the synapse.<xref ref-type="bibr" rid="article-25841.r17">[17]</xref></p>
        <p>Norepinephrine is involved in the pathogenesis of neuropsychiatric disorders. Changes in locus coeruleus firing, dysregulation of norepinephrine function, synaptic receptor regulation, and norepinephrine availability are what result in pathogenesis. Conditions related to norepinephrine dysfunction include anxiety disorders, mood disorders, attention-deficit hyperactivity disorder, Alzheimer&#x02019;s disease, and posttraumatic stress disorder. Furthermore, many symptoms in these disorders are directly attributable to norepinephrine dysfunction in the neural circuitry.<xref ref-type="bibr" rid="article-25841.r18">[18]</xref></p>
        <p>A prominent contributor to the pathogenesis of IgE-mediated diseases is the neurotransmitter histamine. Produced in mast cells, histamine exerts its effects in the body by binding to certain histamine receptors. Two of the cardinal features of asthma, bronchospasm, and mucosal edema, are directly related to histamine receptor stimulation.<xref ref-type="bibr" rid="article-25841.r19">[19]</xref> Histamine is also implicated in the pathogenesis of multiple sclerosis, which is characterized by inflammatory demyelination in the central nervous system. In animal models, histamine has been shown to change the blood-brain barrier permeability. This change in permeability led to an increase of cells infiltrating the central nervous system, subsequently increasing neuroinflammation.<xref ref-type="bibr" rid="article-25841.r20">[20]</xref></p>
      </sec>
      <sec id="article-25841.s7">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25841&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25841">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25841/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25841">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25841.s8">
        <fig id="article-25841.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Anatomy of Neurons. A. Two connected neurons. Neurons have a soma that contains&#x000a0;a nucleus, an axon, and a dendritic tree. A single synapse (red circle) is formed at the point where&#x000a0;an&#x000a0;axon's neuron (black) connects to another neuron's dendrite, soma,&#x000a0;or axon (blue). B. A magnified view of a single synapse. On the arrival of an action potential at the presynaptic terminal, calcium&#x000a0;triggers the release of neurotransmitters from the synaptic vesicles into the synaptic cleft. Neurotransmitters diffuse across the synaptic cleft to activate postsynaptic receptors. Contributed by K Aubrey, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Aubrey__Synapse__Figure__1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25841.s9">
        <title>References</title>
        <ref id="article-25841.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rizo</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Mechanism of neurotransmitter release coming into focus.</article-title>
            <source>Protein Sci</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>27</volume>
            <issue>8</issue>
            <fpage>1364</fpage>
            <page-range>1364-1391</page-range>
            <pub-id pub-id-type="pmid">29893445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herlenius</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lagercrantz</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Neurotransmitters and neuromodulators during early human development.</article-title>
            <source>Early Hum Dev</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-37</page-range>
            <pub-id pub-id-type="pmid">11520626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herlenius</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lagercrantz</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Development of neurotransmitter systems during critical periods.</article-title>
            <source>Exp Neurol</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>190 Suppl 1</volume>
            <fpage>S8</fpage>
            <page-range>S8-21</page-range>
            <pub-id pub-id-type="pmid">15498537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhou</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Danbolt</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>Glutamate as a neurotransmitter in the healthy brain.</article-title>
            <source>J Neural Transm (Vienna)</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>121</volume>
            <issue>8</issue>
            <fpage>799</fpage>
            <page-range>799-817</page-range>
            <pub-id pub-id-type="pmid">24578174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gross</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>"Supporting" players take the lead in protecting the overstimulated brain.</article-title>
            <source>PLoS Biol</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>4</volume>
            <issue>11</issue>
            <fpage>e371</fpage>
            <pub-id pub-id-type="pmid">20076484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bowery</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Smart</surname>
                <given-names>TG</given-names>
              </name>
            </person-group>
            <article-title>GABA and glycine as neurotransmitters: a brief history.</article-title>
            <source>Br J Pharmacol</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>147 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>S109</fpage>
            <page-range>S109-19</page-range>
            <pub-id pub-id-type="pmid">16402094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ko</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Strafella</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging.</article-title>
            <source>Neuroscientist</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>149</fpage>
            <page-range>149-68</page-range>
            <pub-id pub-id-type="pmid">21536838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>The expanded biology of serotonin.</article-title>
            <source>Annu Rev Med</source>
            <year>2009</year>
            <volume>60</volume>
            <fpage>355</fpage>
            <page-range>355-66</page-range>
            <pub-id pub-id-type="pmid">19630576</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Donnell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zeppenfeld</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>McConnell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pena</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nedergaard</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Norepinephrine: a neuromodulator that boosts the function of multiple cell types to optimize CNS performance.</article-title>
            <source>Neurochem Res</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>37</volume>
            <issue>11</issue>
            <fpage>2496</fpage>
            <page-range>2496-512</page-range>
            <pub-id pub-id-type="pmid">22717696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Passani</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Panula</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Histamine in the brain.</article-title>
            <source>Front Syst Neurosci</source>
            <year>2014</year>
            <volume>8</volume>
            <fpage>64</fpage>
            <pub-id pub-id-type="pmid">24808830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>S&#x000fc;dhof</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Neurotransmitter release: the last millisecond in the life of a synaptic vesicle.</article-title>
            <source>Neuron</source>
            <year>2013</year>
            <month>Oct</month>
            <day>30</day>
            <volume>80</volume>
            <issue>3</issue>
            <fpage>675</fpage>
            <page-range>675-90</page-range>
            <pub-id pub-id-type="pmid">24183019</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lau</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tymianski</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Glutamate receptors, neurotoxicity and neurodegeneration.</article-title>
            <source>Pflugers Arch</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>460</volume>
            <issue>2</issue>
            <fpage>525</fpage>
            <page-range>525-42</page-range>
            <pub-id pub-id-type="pmid">20229265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chandran</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mattson</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>DJ-1 is essential for long-term depression at hippocampal CA1 synapses.</article-title>
            <source>Neuromolecular Med</source>
            <year>2008</year>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-5</page-range>
            <pub-id pub-id-type="pmid">18246449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dong</surname>
                <given-names>XX</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Qin</surname>
                <given-names>ZH</given-names>
              </name>
            </person-group>
            <article-title>Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases.</article-title>
            <source>Acta Pharmacol Sin</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>379</fpage>
            <page-range>379-87</page-range>
            <pub-id pub-id-type="pmid">19343058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jembrek</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Vlainic</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>GABA Receptors: Pharmacological Potential and Pitfalls.</article-title>
            <source>Curr Pharm Des</source>
            <year>2015</year>
            <volume>21</volume>
            <issue>34</issue>
            <fpage>4943</fpage>
            <page-range>4943-59</page-range>
            <pub-id pub-id-type="pmid">26365137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rangel-Barajas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Coronel</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Flor&#x000e1;n</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Dopamine Receptors and Neurodegeneration.</article-title>
            <source>Aging Dis</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>6</volume>
            <issue>5</issue>
            <fpage>349</fpage>
            <page-range>349-68</page-range>
            <pub-id pub-id-type="pmid">26425390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coppen</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Doogan</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Serotonin and its place in the pathogenesis of depression.</article-title>
            <source>J Clin Psychiatry</source>
            <year>1988</year>
            <month>Aug</month>
            <volume>49 Suppl</volume>
            <fpage>4</fpage>
            <page-range>4-11</page-range>
            <pub-id pub-id-type="pmid">3045111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ressler</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Nemeroff</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Role of norepinephrine in the pathophysiology of neuropsychiatric disorders.</article-title>
            <source>CNS Spectr</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>6</volume>
            <issue>8</issue>
            <fpage>663</fpage>
            <page-range>663-6, 670</page-range>
            <pub-id pub-id-type="pmid">15520614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akagi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Histamine in the pathogenesis of asthma].</article-title>
            <source>Nihon Yakurigaku Zasshi</source>
            <year>1998</year>
            <month>Apr</month>
            <volume>111</volume>
            <issue>4</issue>
            <fpage>217</fpage>
            <page-range>217-22</page-range>
            <pub-id pub-id-type="pmid">9618706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25841.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jadidi-Niaragh</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mirshafiey</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis.</article-title>
            <source>Neuropharmacology</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>180</fpage>
            <page-range>180-9</page-range>
            <pub-id pub-id-type="pmid">20493888</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
